• FirefoxInstall the new Firefox »
  •  Dow Down 0.57% Nasdaq Down 0.73%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    121.60 Up 1.43(1.19%) 1:57PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:120.17
    Open:120.06
    Bid:121.16 x 300
    Ask:121.25 x 100
    1y Target Est:134.50
    Beta:-0.7
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:119.11 - 121.64
    52wk Range:59.79 - 127.69
    Volume:570,510
    Avg Vol (3m):1,620,330
    Market Cap:29.44B
    P/E (ttm):N/A
    EPS (ttm):-3.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXUp 1.19%29.44B
    BMYDown 0.91%102.60B
    MRKDown 0.75%165.01B
    PTCTDown 1.84%2.27B

    Key Statistics

    Forward P/E (1 yr):30.40
    P/S (ttm):50.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.51
    Quarterly EPS Est (Mar-15) :-0.71
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-2.66

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback